$2.43T
Total marketcap
$72.89B
Total volume
BTC 50.66%     ETH 14.92%
Dominance

Boiron SA BON.F Stock

34.25 EUR {{ price }} 1.632045% {{change_pct}}%
COUNTRY
Germany
Exchange
Frankfurt
Market Cap
595.14M EUR
LOW - HIGH [24H]
34.25 - 34.25 EUR
VOLUME [24H]
8 EUR
{{ volume }}
P/E Ratio
12.50
Earnings per share
2.74 EUR

Boiron SA Price Chart

Boiron SA BON.F Financial and Trading Overview

Boiron SA stock price 34.25 EUR
Previous Close 37.6 EUR
Open 38.1 EUR
Bid 38.25 EUR x 20000
Ask 39 EUR x 20000
Day's Range 38.1 - 38.1 EUR
52 Week Range 36.9 - 51.7 EUR
Volume 13 EUR
Avg. Volume 21 EUR
Market Cap 668.41M EUR
Beta (5Y Monthly) 0.408812
PE Ratio (TTM) 13.13793
EPS (TTM) 2.74 EUR
Forward Dividend & Yield 1.1 (2.89%)
Ex-Dividend Date June 1, 2023
1y Target Est N/A

BON.F Valuation Measures

Enterprise Value N/A
Trailing P/E 13.13793
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 1.251151
Price/Book (mrq) 1.2421347
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Boiron SA Stock Price History

Beta (5Y Monthly) 0.408812
52-Week Change -2.67%
S&P500 52-Week Change 20.43%
52 Week High 51.7 EUR
52 Week Low 36.9 EUR
50-Day Moving Average 38.82 EUR
200-Day Moving Average 43.15 EUR

BON.F Share Statistics

Avg. Volume (3 month) 21 EUR
Avg. Daily Volume (10-Days) 1 EUR
Shares Outstanding 17.36M
Float N/A
Short Ratio N/A
% Held by Insiders 75.48%
% Held by Institutions 9.13%
Shares Short N/A
Short % of Float N/A
Short % of Shares Outstanding N/A

Dividends & Splits

Trailing Annual Dividend Rate 1.1
Trailing Annual Dividend Yield 2.92%
5 Year Average Dividend Yield 296.00%
Payout Ratio 0.32869998
Last Split Factor 4:1

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) December 31, 2022
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 8.36%
Operating Margin (ttm) 12.80%
Gross Margin 71.07%
EBITDA Margin 16.78%

Management Effectiveness

Return on Assets (ttm) 5.48%
Return on Equity (ttm) 8.13%

Income Statement

Revenue (ttm) 534.24M EUR
Revenue Per Share (ttm) N/A
Quarterly Revenue Growth (yoy) 4.59%
Gross Profit (ttm) 379.73M EUR
EBITDA 89.69M EUR
Net Income Avi to Common (ttm) 44.67M EUR
Diluted EPS (ttm) 2.9
Quarterly Earnings Growth (yoy) -15.59%

Balance Sheet

Total Cash (mrq) 250.94M EUR
Total Cash Per Share (mrq) N/A
Total Debt (mrq) 22.17M EUR
Total Debt/Equity (mrq) 3.98 EUR
Current Ratio (mrq) 3.119
Book Value Per Share (mrq) 30.673

Cash Flow Statement

Operating Cash Flow (ttm) N/A
Levered Free Cash Flow (ttm) N/A

Profile of Boiron SA

Country Germany
State N/A
City Messimy
Address 2, avenue de l’Ouest Lyonnais
ZIP 69510
Phone 33 4 78 45 61 00
Website https://www.boiron.fr
Industry Drug Manufacturers-Specialty & Generic
Sector(s) Healthcare
Full Time Employees 2801

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Q&A For Boiron SA Stock

What is a current BON.F stock price?

Boiron SA BON.F stock price today per share is 34.25 EUR.

How to purchase Boiron SA stock?

You can buy BON.F shares on the Frankfurt exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Boiron SA?

The stock symbol or ticker of Boiron SA is BON.F.

Which industry does the Boiron SA company belong to?

The Boiron SA industry is Drug Manufacturers-Specialty & Generic.

How many shares does Boiron SA have in circulation?

The max supply of Boiron SA shares is 17.38M.

What is Boiron SA Price to Earnings Ratio (PE Ratio)?

Boiron SA PE Ratio is 12.50000000 now.

What was Boiron SA earnings per share over the trailing 12 months (TTM)?

Boiron SA EPS is 2.74 EUR over the trailing 12 months.

Which sector does the Boiron SA company belong to?

The Boiron SA sector is Healthcare.